Rep. LANDING proposes the following amendment (LC-287.VR0015H):

Amend the bill, as and if amended, SECTION 1, by striking Section 44-95-65(B)(1) and inserting:

  (1) the ENDS product was on the market in the United States as of August 8, 2016, and the manufacturer has applied for a marketing order pursuant to 21 U.S.C. Section 387j for the ENDS product by submitting a premarket tobacco product application on or before September 9, 2020, to the FDA and either the premarket tobacco product application for the product remains under review by the FDA or the FDA has issued a marketing denial order for the product from the FDA but the agency or a federal court has issued a stay order or injunction; or

Amend the bill further, SECTION 1, by striking Section 44-95-65(C) and inserting:

 (C) In addition to the requirements in subsection (B) of this section, each manufacturer shall provide either a copy of the acceptance letter or Submission Tracking Number issued by the FDA pursuant to 21 U.S.C. Section 387j for a timely filed premarket tobacco application, a copy of the marketing granted order issued pursuant to 21 U.S.C. Section 387j, or a document issued by the FDA or by a court confirming that the premarket tobacco product application received a denial order that has been and remains stayed by the FDA or court order, rescinded by the FDA, or vacated by a court.

Renumber sections to conform.

Amend title to conform.